Seroprevalence of hepatitis B and syphilis co-infection in human immunodeficiency virus-positive antiretroviral therapy attendees and human immunodeficiency virus-negative sexually transmitted infection attendees
Sir, Sexually transmitted diseases (STDs) remain a public health problem of major significance in most part of the world. India has the second highest number of people living with human immunodeficiency virus (HIV). [1] The presence of genital ulcers (syphilis) significantly increases the transmission of HIV to sexual partner. Recent outbreaks of syphilis and increase in hepatitis B cases have raised concern regarding the potential enhancement of STDs. It has recently been found that HIV-positive patients with hepatitis B virus (HBV) co-infection are associated with increased risk of progression to severe hepatotoxicity due to antiretroviral therapy (ART) and reduced survival of the patient. [2] Therefore, there is a serious need to consider anti-HBV therapy in addition to ART in those with dual infection. Among 250 STI patients, 5 (2.0%) were HBsAg positive, 2 (0.8%) were positive for syphilis, and 1 (0.4%) were positive for HIV.
From 250 HIV positive (ART) patients, 14 (5.6%) were positive for HBsAg, and 5 (2.0%) were positive for syphilis.
In our study, the prevalence of syphilis in ART patients and STI patients was 5 (2.0%) and (0.8%), respectively. However, Kyriaks et al. reported the prevalence of syphilis among 7.8% of ART patients, may be due to unawareness in patients.
HBsAg prevalence in STI attendees was very low (2%) in our study. However, higher prevalence (8.8%) of HBsAg co-infection was found in study by Risbud et al. [3] The present study showed 5.6% prevalence of HBsAg in ART attendees which are in concordance with 4.9% prevalence in study by Ahuja et al. [4] A very high prevalence of 19.5% co-infection of HBV in a study in from Rajkot, [5] and 10% of HBV co-infection was observed in study performed in Maharashtra, the state with high HIV patients load. Thus, HbsAg co-infection with HIV patients varies in different parts of India. This difference in prevalence in co-infection may be because of the stage of disease and different geographical area among HIV patients in study group.
HIV-positive patients were more likely than HIV-negative to be infected with syphilis (2% vs. 0.8%, respectively) as well as hepatitis B (5.6% vs. 2.0%, respectively).
Overall, the prevalence of co-infection of hepatitis B and syphilis were found higher in ART attendees than the STI attendees. Therefore, this study does not necessities the need for a routine screening test for syphilis and hepatitis B in patients attending STI clinic in a resource poor country like India. However, HIV-infected individuals with high probability of getting co-infected with HBV and syphilis should be considered for screening as a routine protocol.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Co-infection of hepatitis B virus and hepatitis C virus with human immunodeficiency virus infection: A cross-sectional study
Sir, Patients with human immunodeficiency virus/hepatitis B virus (HIV/HBV) infection have more severe liver disease and higher liver-related mortality rates than do HBV-monoinfected persons. [1] The tolerability of HIV medications can be adversely affected by the presence of HBV co-infection. [2] Some but not all studies suggest that drug-induced hepatotoxicity may be more common among patients with HIV/hepatitis C virus (HCV) co-infection, particularly with the use of HIV-1 proteases inhibitors, and antituberculosis drugs. [3] Globally, there are some 370 million persons persistently infected with HBV, with 2-4 million individuals estimated to be co-infected with HIV, and chronic HBV. [4] The main aim of the study was to know the prevalence of HBV and HCV co-infection with HIV in our region. Patients with HIV infection, who attended our dermatology and sexually transmitted infection (STI) clinic at a tertiary health care center for skin/STI problems, were included. Diagnosis of HIV infection was done by kits provided by the NACO. Diagnosis of HBV infection was done by detection of hepatitis B surface antigen. Infection of HCV was detected by enzyme-linked immunosorbent assay. Route of HIV transmission and profession of the patients were recorded by detailed history. Four hundred and twenty-two patients (258 males and 164 females) were enrolled for the study. The majority of patients were homemakers (39%) followed by laborers (23%) and truck/taxi drivers (15.8%). In majority of patients (91%), route of HIV transmission was heterosexual contact. Out of these, only 14 (3.3%) were found to be infected with HBV infection. Among HBV positive patients, 13 were males and one was female. In most of the patients (13 patients), HBV infection was transmitted through heterosexual contact. One patient acquired infection through his mother. One hundred forty-five patients were tested for HCV, but none of the patients was found to be infected with HCV. Systematic review and meta-analysis of the prevalence of hepatitis B in India revealed true prevalence in nontribal populations is 2.4% (95% confidence interval [CI]: 2.2-2.7%). True prevalence among tribal populations is 15.9% (CI: 11.4-20.4%). [5] Our study showed co-infection of HBV with HIV is less, and HCV co-infection is rare in our region.
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